Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1423053 MIAMI, FL
Back to ADPT Full portfolio

Position in ADPT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$0
+$0 QoQ
Shares Held
45,339
-50.1% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Derivatives in ADPT

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
19,250
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,695,016,013 across 33 Diagnostics & Research names. ADPT ranks #33 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 574,992 $288,277,988
2 CRL
Charles River Laboratories International, Inc.
 1,193,601 $270,696,770
3 GH
Guardant Health, Inc.
 1,449,534 $217,473,585
4 DHR
Danaher Corp /De/
 943,694 $179,754,833
5 RVTY
Revvity, Inc.
 1,457,335 $162,143,091
6 A
Agilent Technologies, Inc.
 1,101,501 $146,312,377
7 NTRA
Natera, Inc.
 265,607 $72,099,020
8 WGS
GeneDx Holdings Corp.
 865,462 $59,413,965

All Filings in ADPT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 — 181,356
2026-06-30 — 77,000
2026-03-31 — 363,333
2026-03-31 — 14,600
2025-12-31 — 21,800
2025-12-31 — 56,952
2025-09-30 — 28,084
2025-09-30 — 12,000
2025-06-30 — 800,689
2025-06-30 — 18,000
2025-03-31 — 27,500
2025-03-31 — 18,600
2025-03-31 — 144,338
2024-12-31 — 6,800
2024-12-31 — 226,982
2024-12-31 — 8,500
2024-09-30 — 37,700
2024-09-30 — 209,426
2024-09-30 — 29,500
2024-06-30 — 15,500
2024-06-30 — 8,400
2024-06-30 — 402,122
2024-03-31 — 10,400
2024-03-31 — 2,600
2024-03-31 — 81,898
2023-12-31 — 39,300
2023-12-31 — 12,800
2023-12-31 — 2,871
2023-09-30 — 17,400
2023-09-30 — 143,992
2023-09-30 — 9,900
2023-06-30 — 13,900
2023-06-30 — 714,522
2023-06-30 — 22,100
2023-03-31 — 29,600
2023-03-31 — 802,503
2023-03-31 — 10,300
2022-12-31 — 15,800
2022-12-31 — 543,278
2022-12-31 — 45,200
2022-09-30 — 35,000
2022-09-30 — 835,815
2022-09-30 — 22,200
2022-06-30 — 42,100
2022-06-30 — 401,569
2022-06-30 — 27,400
2022-03-31 — 44,700
2022-03-31 — 70,400
2022-03-31 — 201,871
2021-12-31 — 20,400